CERE - Cerevel Therapeutics drops amid report on FTC review of AbbVie deal
2024-07-03 12:04:34 ET
More on Cerevel Therapeutics
- Cerevel Therapeutics: Time For A Risk Arbitrage Play?
- Cerevel Therapeutics gains on report Tempur Sealy will be the subject of FTC meeting (update)
- Cerevel Therapeutics sinks amid some worry on FTC review of AbbVie deal
- Seeking Alpha’s Quant Rating on Cerevel Therapeutics
- Historical earnings data for Cerevel Therapeutics